Delivery Order SPE2DR25D3016-SPE2DR26FG2LS
- Not listed
- The Defense Logistics Agency awarded a $63,022.10 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Darzalex Faspro 1,800 mg–30,000 unit 15 ml vials. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 26, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract contains no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a $18,906.63 delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This is a firm fixed price, non-set-aside contract with a completion date of December 31, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $23,920.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with completion scheduled for December 2, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $119,604.20 to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with completion targeted for October 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order issued under AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a $107,643.78 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with an ultimate completion date of October 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical products, with a contract ceiling value of $478,416.80. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by October 6, 2025, and will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This non-set-aside, competitively awarded delivery order carries a ceiling value of $95,683.36 under a firm fixed price contract type, with an ultimate completion date of August 29, 2025. The award was made on August 8, 2025, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a $59,802.10 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of September 17, 2025, was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order issued under...
- The Defense Logistics Agency awarded a $37,813.26 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Darzalex Faspro (daratumumab) 1,800 mg-30,000 IU in 15 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by December 18, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a $35,881.26 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with performance completion targeted for September 9, 2025. This non-competitive delivery order employs firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through...
- SPE2DR25D3016Indefinite Delivery Contract
- SPE2DR25D3016-SPE2DR26FG2LSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This is a firm fixed price delivery order with a ceiling value of $12,604.42 and an ultimate completion date of January 13, 2026. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor serving defense and healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's federal contracting history demonstrates extensive experience fulfilling diverse pharmaceutical supply requirements through DLA, ranging from specialty medications and brand-name drugs to vaccines and medical supplies across multiple therapeutic domains. This delivery order for Darzalex Faspro—an oncology medication used in multiple myeloma treatment—reflects AmerisourceBergen's ongoing role as a key supplier for military healthcare pharmaceutical needs within the DLA's global pharmaceutical support network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.6k | 12/18/25 |